SMC approves funding for four new medicines on the NHS by Lucy Parsons | Feb 9, 2021 | News | 0 BMS’ MS therapy Zeposia and AbbVie’s JAK inhibitor Rinvoq among latest approvals Read More
NICE no for BMS’ multiple sclerosis drug Zeposia by Lucy Parsons | Jan 22, 2021 | News | 0 Cost-effectiveness estimates ‘uncertain’, according to NICE Read More
BMS’ Zeposia hits the mark in ulcerative colitis by Lucy Parsons | Oct 12, 2020 | News | 0 Oral S1P receptor modulator hit both primary endpoints in a phase III trial Read More